Table 2.
Ultrasound parameters of cardiac performance in Ctrl and RVH rats before and after treatment with NaHS.
| SAX M-Model parameters | Ctrl (n = 5) | RVH (n = 5) | Ctrl + NaHS-4w (n = 5) | RVH + NaHS-4w (n = 5) |
|---|---|---|---|---|
| LVAWd | 2.00 ± 0.27 | 2.91 ± 0.39** | 2.18 ± 0.48 | 2.24 ± 0.15† |
| LVAWs | 3.05 ± 0.4 | 4.05 ± 0.58* | 3.61 ± 0.26 | 3.24 ± 0.29† |
| LVIDd | 5.54 ± 0.83 | 5.44 ± 0.53 | 5.75 ± 0.47 | 5.93 ± 0.39 |
| LVIDs | 2.25 ± 0.68 | 2.46 ± 0.44 | 2.56 ± 0.57 | 2.90 ± 0.39 |
| LVPWd | 1.80 ± 0.22 | 2.34 ± 0.53 | 2.33 ± 0.41 | 1.96 ± 0.16 |
| LVPWs | 3.35 ± 0.31 | 3.40 ± 0.49 | 3.69 ± 0.24 | 3.05 ± 0.38 |
| EF(%) | 88.2 ± 6.06 | 85.2 ± 4.46 | 84.7 ± 7.01 | 80.3 ± 7.81 |
| FS(%) | 60.0 ± 8.11 | 55.4 ± 5.42 | 55.7 ± 8.89 | 51.2 ± 4.58 |
All data were presented as mean ± SD, *P < 0.05 and **P < 0.01 vs. Ctrl, †P < 0.05 vs. RVH group.
Ctrl control rats, RVH renal vascular hypertension rats, NaHS NaHS by intraperitoneal injection for 4 weeks (4w), EF ejection fraction, FS fractional shortening, LVAWs/LVAWd systolic/diastolic left ventricular anterior wall, LVIDs/LVIDd systolic/diastolic left ventricular internal diameter, LVPWs/LVPWd systolic/diastolic left ventricular posterior wall, SAX short axis.